A China-developed Covid-19 vaccine could be ready for public usage as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Chinese manufacturers have been bullish about development, with companies Sinovac Biotech and Sinopharm even putting their vaccine candidates on display at a trade fair in Beijing this month.
Representatives of the firms told AFP that they hope their vaccines will be approved after phase 3 trials as early as year-end.
And on late Monday, the chief biosafety expert at the Chinese Centre for Disease Control told state broadcaster CCTV that a vaccine would be available to the general public “around November or December.”
Wu Guizhen did not specify which vaccine she was referring to, but said “based on the phase 3 clinical results, the current progress is very smooth.”about:blank
Wu also said that she had taken a vaccine in April and has felt good over the past few months, although she did not specify which candidate she had taken.
There are currently nine vaccine candidates in late-stage human trials, although some have hit recent obstacles — pharma giant AstraZeneca and Oxford University momentarily paused clinical trials last week after a volunteer developed an unexplained illness.
Some of China’s vaccine candidates have already been offered to essential workers under an emergency use programme.
A Sinovac spokesman told AFP this month that “tens of thousands” of people had voluntarily taken its vaccine, including 90 percent of its employees and their families between 2,000 and 3,000 people.
You may also like
France President Macron Says Russia Must Answer For War Crimes In Bucha Ukraine
Seven Countries Jointly Call On Taliban To Ensure Rights
Two Russian soldiers killed and 28 ill ‘after being given poisoned food by Ukrainian civilians’
Africa’s richest man, Aliko Dangote, Gains extra $915 million to his wealth in Q1 2022
British ‘Tinder Swindler’ pleads guilty after woman scammed of £157,000